36C24720Q0956_1.docx

DOCX document 160 KB Posted

Attached to
Q527--Radiopharmaceuticals B+4 Federal contract opportunity
Solicitation number
36C24720Q0956
Issued by
Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7

About this file

This is a solicitation for radiopharmaceutical supplies and services to be provided to the Department of Veterans Affairs Charlie Norwood VA Medical Center in Augusta, Georgia. The requirement will utilize a 100% total Service Disabled Veteran Owned Small Business set-aside and utilize a firm fixed price commercial items contract evaluated using low price technically acceptable factors. The period of performance is a base year starting September 1, 2020 through August 31, 2021 with four one-year option periods. Products and services required include radiopharmaceutical unit doses, cyclotron services, dose calibration sources, waste disposal kits, and dose management software. Delivery requirements include routine weekday and emergency delivery timeframes. Offerors must register in SAM and carefully review amendments posted to the solicitation on Beta SAM. Questions must be sent by email to the contracting officer by the response date listed in the presolicitation notice.

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

36C24720Q0956

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a. PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

DUNS:

DUNS+4:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA

26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. 2/2012)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

509-20-4-054-0021 36C24720Q0956 07-28-2020

DARRELL HARPER

478-278-1587 08-04-2020

1:00 PM

Department of Veterans Affairs Carl Vinson VA Medical Center 1826 Veterans Blvd.

Dublin GA 31021 X X 325412 1250 Employees

NET 30

N/A X See Delivery Schedule

Department of Veterans Affairs Carl Vinson VA Medical Center 1826 Veterans Blvd.

Dublin GA 31021

Department of Veterans Affairs

FMS-VA-2(101)

Financial Services Center PO Box 149971 Austin TX 78714-9971 See CONTINUATION Page The contractor shall provide all Radiopharmaceutical items listed on the Price/Cost Schedule IAW the attached SOW. The contract is a Base plus 4 Option years contract.

Base Year: 9/1/2020 - 8/31/2021 Option Year 1: 9/1/2021 - 8/31/2022 Option Year 2: 9/1/2022 - 8/31/2023 Option Year 3: 9/1/2023 - 8/31/2024 Option Year 4: 9/1/2024 - 8/31/2025 See CONTINUATION Page X X X

JAMES E. BOLES JR.

CONTRACTING OFFICER

Table of Contents

SECTION A1
A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS1
SECTION B - CONTINUATION OF SF 1449 BLOCKS3
B.1 CONTRACT ADMINISTRATION DATA3
B.2 PRICE/COST SCHEDULE14
ITEM INFORMATION14
B.3 DELIVERY SCHEDULE40
SECTION C - CONTRACT CLAUSES51
C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL ITEMS (OCT 2018)51
C.2 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)57
C.3 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000)57
C.4 VAAR 852.212-70 PROVISIONS AND CLAUSES APPLICABLE TO VA ACQUISITION OF COMMERCIAL ITEMS (APR 2020)57
C.5 VAAR 852.219-74 LIMITATIONS ON SUBCONTRACTING—MONITORING AND COMPLIANCE (JUL 2018)59
C.6 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018)60
C.7 VAAR 852.270-1 REPRESENTATIVES OF CONTRACTING OFFICERS (JAN 2008)61
C.8 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)61
C.9 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL ITEMS (JUN 2020)62
SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS70
SECTION E - SOLICITATION PROVISIONS71
E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL ITEMS (OCT 2018)71
E.2 52.216-1 TYPE OF CONTRACT (APR 1984)75
E.3 52.219-27 NOTICE OF SERVICE-DISABLED VETERAN-OWNED SMALL BUSINESS SET-ASIDE (MAR 2020)75
E.4 52.233-2 SERVICE OF PROTEST (SEP 2006)77
E.5 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998)77
E.6 52.212-2 EVALUATION—COMMERCIAL ITEMS (OCT 2014)78
E.7 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL ITEMS (JUN 2020)78

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C247 JAMES E. BOLES JR.

Department of Veterans Affairs Carl Vinson VA Medical Center 1826 Veterans Blvd.

Dublin GA 31021

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X]
52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or
[X]
52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly[]
b. Semi-Annually[]
c. Other[X] Monthly

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

Department of Veterans Affairs

FMS-VA-2(101)

Financial Services Center PO Box 149971 Austin TX 78714-9971 ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO
DATE

36C24720Q0956

Page 1 of

STATEMENT OF WORK

A. GENERAL INFORMATION

1. Title of Project: Statement of Work - Radiopharmaceutical Supplies

2. Scope of Work: Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents to diagnose specific pathologies such as Cancer, Osteomyelitis, Cardiac Ischemia and Infection just to name a few. While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and still most common such drugs.

The Charlie Norwood VA Medical Center, (CNVAMC) requires a Contractor to provide all unit dose Radiopharmaceuticals used by the Nuclear Medicine Imaging Department, during normal working hours and for all after hour emergency studies. The Contractor shall provide routine weekday (Monday thru Friday) deliveries of Technetium-99m Sodium Pertechnetate, Technetium-99m Medronate, Technetium-99m MAA, and Technetium-99m Tetrofosmin or Sestamibi delivered to the Nuclear Medicine Section of Radiology Service no later than 8:00 am local time. Additional items may be added to the standing order if requested. The Contractor shall provide all resources necessary to accomplish the deliverables described in this statement of work, except as may otherwise be specified.

A firm fixed-price contract is planned and shall be advertised as open market on FedBizOps.gov.

The basis of award shall be Lowest Price Technically Acceptable (LPTA).

3. Background: The Contractor shall supply radiopharmaceutical products as listed in Section B.2, Price/Cost Schedule of this solicitation in accordance with Public Law 104-262 and 38 USC 8153 for the Department of Veterans Affairs Medical Center, Augusta, Georgia. The Contractor shall be licensed by the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals.

4. Performance Period:

The period of performance is FY 20 Q4 (09/01/2020 through 08/31/2021), with four option years.

Normal working hours for the Nuclear Medicine Service at CNVAMC are Monday through Friday, 7:00 a.m. through 3:30 p.m. Services may be required after normal operating hours during the week and on weekends and holidays for emergency patient care. See Section F for list of observed Federal Holidays.

B. GENERAL REQUIREMENTS

Anticipated Supplies required based on 12 months usage in FY 2019 (Jan 1, 2019 through Dec 31, 2019):

Page 1 of

Page 1 of Generator or pre-ordered products:

I123 NaI, 200 uCi capsule: 100 capsules I123 NaI diagnostic capsule 2 – 4 mCi 150 capsules I131 NaI, therapy capsules, 1 – 200 mCi 40 capsules In111 DTPA, 0.5 mCi: 1 dose In111 Octreoscan, 1 – 25 mCi: 5 doses In111 labeled WBC, 0.5 mCi: 20 doses In111 labeled WBC KIT: 20 doses Tc99m Exametazine UD: 1 dose Tc99m MAA, 1 – 6 mCi: 40 doses Tc99m DTPA(Lung), 40 – 45 mCi: 40 doses Tc99m MAG3, 10 mCi vials: 30 doses Tc99m MDP, 25 mCi: 200 doses Tc99m Mebrofenin, 5 – 10 mCi: 50 doses Tc99m Sestamibi, 10 – 30 mCi: 1800 doses Tc99m Sulfur Colloid, 1 – 8 mCi: 40 doses Tc99m Filtered Sulfur Colloid, .25 – 2 mCi - 2 doses Tc99m Lymphoseek: 5 doses (if possible) Tc99m DTPA (Renal), 7 – 10 mCi: 10 doses Tc99m labeled WBC, 0.5 mCi:5 doses Tc99m labeled WBC KIT: 5 doses Tc99m NaTcO4, 1-30 mCi: 75 doses Tc99m NaTcO4, 4-200 mCi vials: 1000 vials Tl201, 3.5 mCi: 5 doses PYP Cold kits – 40 kits Geiger Muller Survey Calibration: 6 calibrations Return Kit MED 3709 Return Kit BM01-15 MED3709 20 mCi Sheet Source: 1 ea.

Pharmacist Call Out Fee: 10 ea.

I123 DaTscan (Iouflupane) (if possible)

Cyclotron Products:

F18 – Fluorine Deoxy glucose (FDG),10-13mCi: 900 doses
F-18- Axumin (Fluciclovine) 10 -13 mCi : 20 doses (if possible)

1. The Contractor shall provide unit dose syringes of F-18 FDG for PET imaging on a daily basis as ordered by the Nuclear Medicine Section.

2. The Contractor shall provide all radiopharmaceuticals in multidose vials or single dose containers as specified. The cost of each radiopharmaceutical will be calculated on a per vial, per syringe, or a per millicurie amount as indicated in contract pricing.

3. The Contractor shall provide quarterly Technetium-99m Sodium Pertechnetate dose calibrator linearity source of approximately 350 millicuries in 10 cc’s of saline and in a 10cc vial. F-18 FDG or fluorinated water shall be provided as required by the physicist for PET quality assurance.

4. The contractor shall provide, as needed, additional radiopharmaceuticals, as soon as possible but within a one to two (1-2) hour time frame during normal duty hours (08:00 to 16:30) including F-18 FDG.

5. Contractor shall provide Leucocyte and platelet labeling with radioactive material and will return the labeled cells to Charlie Norwood VA Medical Center within one (1) hour of the finish of the labeling process. The entire process MUST be performed in one (1) day.

6. The Contractor shall provide 24 -hour on-call services and will be required to provide needed services and radiopharmaceuticals as soon as possible but within a one to two (1-2) hour time basis.

7. Payment shall be made for only those orders specifically requested by the Charlie Norwood VA Medical Center Nuclear Medicine Technologists.

8. The Contractor agrees to provide USP 797 prepared single unit doses of radiopharmaceuticals and associated materials to CNVAMC as ordered and at the agreed upon price.

9. The Contractor shall be responsible for manufacturing and delivery of sterile/aseptic, USP 797 compliant, low enriched uranium (LEU) radiopharmaceuticals for diagnosis and treatment of patients receiving services at the CNVAMC. Low Enriched Uranium Technetium shall be provided, when at all possible, as mandated by VA Central Office.

10. Orders shall be placed each day (Monday through Friday by 4:30PM) for delivery the next business day (Monday through Friday). Due to the demands of the Medical Center patient care requirements, Contractor shall provide routine deliveries at no charge.

Proposals will be considered only from Offerors who are regularly established in the business that is called for, and who in the judgment of the Contracting Officer are financially responsible and able to show evidence of the reliability, ability, experience, equipment, facilities and personnel directly employed or supervised by them to render prompt and satisfactory service.

C. SPECIFIC MANDATORY TASKS AND ASSOCIATED DELIVERABLES

1. Contractor shall complete routine and emergency orders for Radiopharmaceutical doses and calibration times. The Contractor must also ensure proper inventory and receipt of the shipment is completed by qualified personnel. The Contractor will calibrate all Radiopharmaceutical doses to ensure proper activity ranges of +/- 10 percent of the specified ordered dose based on specific requirements provided by the Nuclear Medicine Supervisor based on guidelines outlined in 10 CFR Part 35.

· Routine Orders are scheduled the day prior and/or during the workday. A Routine order must be delivered within a 1-hour time period.

· Stat Orders are orders that MUST be delivered within a 30-minute window for emergency patients.

· Scheduled Orders must be delivered 30 minutes prior to the requested scheduled date and time.

2. Contractor shall ensure that all Radiopharmaceuticals doses are compounded according to USP 797 and calibrated by or under the supervision of a certified Nuclear Medicine Pharmacist.

3. Contractor shall ONLY provide Radiopharmaceuticals approved by the FDA.

4. OIT:

· Contractor shall support or provide a software system mechanism for electronic tracking of radiopharmaceutical receipt, inventory and patient dose administration, including software and hardware support, with emphasis on documentation of quality assurance and regulatory requirements. The software system mechanism shall offer the following minimum functions:

· A TRM approved version of Nuclear Medicine Dose Management Program. This program shall provide all necessary software or internet-based programs. (ie: Syntrac version 3.x, Nuclear Medicine Information System (NMIS) v 19.x, etc.) are TRM (Technical Resource Model) approved and loaded on an OI&T gold-image workstation.

· The TRM helps establish a standard process by which non-VA developed software’s are tested on and approved for use on OI&T gold-image workstations. If a particular software make and version is not TRM approved or loses TRM approval, then OI&T will not allow the software on an OI&T gold-image workstation.

· The management program shall provide daily reporting and monthly record keeping as a centralized, electronic repository for required compliance data so that necessary regulatory compliance documentation is easily compiled to facilitate upcoming inspections.

· Capable of providing radiopharmaceuticals online ordering capabilities that enable sending orders electronically to the pharmacy.

· Provides a method to document the amount of radiation exposure a patient receives throughout a course of treatment and over a period of time.

· Capable of scanning individual dose barcode to an inventory directory.

· Capable of tracking codes and reliable data to assist in collaborative planning.

· If at any time during the contract period, the system becomes faulty, the hardware, software, and back up information becomes property of the VA.

· A Business Associate Agreement between the Department of Veterans Affairs Veterans Health Administration is required for any software to be utilized within the Veterans Administration due to the HIPPA & HITECH Act.

· The Contractor shall provide a detailed explanation of other VA sites in which their offered software is currently provided and the exact set up networking and backup server arrangement.

· The Contractor shall provide a commitment that their software will continue to have TRM approval for the duration of the contract. (For instance, Syntrac version 3.x is approved through calendar year 2021. Software developers do need to ensure that they keep their softwares TRM approved or at least have newer versions in the process of being approved if older versions are being phased out.)

· The systems must remain patched to prevent vulnerabilities, VA users need to ensure sensitive data is protected and must consult with the ISO to ensure compliance, and data shall be encrypted per FIPS 140-2 standards.

· Constraint type 3: Technology must remain patched and operated in accordance with Federal and Department security policies and guidelines in order to mitigate known and future security vulnerabilities.

· Constraint type 5: Veterans Affairs (VA) users must ensure VA sensitive data is properly protected in compliance with all VA regulations. All instances of deployment using this technology should be reviewed by the local ISO (Information Security Officer) to ensure compliance with VA Handbook 6500.

· Constraint type 6: Per the May 5th, 2015 memorandum from the VA Chief Information Security Officer (CISO) FIPS 140-2 Validate Full Disk Encryption (FOE) for Data at Rest in Database Management Systems (DBMS) and in accordance with Federal requirements and VA policy, database management must use Federal Information Processing Standards (FIPS) 140-2 compliant encryption to protect the confidentiality and integrity of VA information at rest at the application level. If FIPS 140-2 encryption at the application level is not technically possible, FIPS 140-2 compliant full disk encryption (FOE) must be implemented on the hard drive where the DBMS resides. Appropriate access enforcement and physical security control must also be implemented. All instances of deployment using this technology should be reviewed to ensure compliance with VA Handbook 6500 and National Institute of Standards and Technology (NIST) standards. It is the responsibility of the system owner to work with the local CIO (or designee) and Information Security Officer (ISO) to ensure that a compliant DBMS technology is selected and that if needed, mitigating controls are in place and documented in a System Security Plan (SSP).

5. Contractor shall provide courier service that is in accordance with Department of Transportation, Nuclear Regulatory Commission (DOT) and other applicable regulating authorities enabling the delivery of all radiopharmaceuticals. All couriers shall be licensed and bonded.

6. Contractor must be licensed by the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals. Offeror must provide copies of licenses and certifications along with quote to the Contracting Officer.

7. Contractor shall provide opportunities for continuing education to the Nuclear Medicine Technologists at the Charlie Norwood VA Medical Center on subjects related to radiopharmaceuticals and other topics closely related to radiopharmaceuticals.

8. Contractor shall be responsible for all costs for any radiopharmaceuticals and nonradioactive items contracted for if the Charlie Norwood VA Medical Center must find an alternate supplier for contracted items.

9. In the event of a manufacturer or pharmacy recall or quality assurance failure, the contractor shall notify the VA Nuclear Medicine Department immediately.

10. Contractor shall have available an adequate supply of contract products to meet the requirements of the CNVAMC at its distribution points.

11. Contractor shall label all supplies as to the amount of radiopharmaceutical, preparation time, expiration time, date, etc. compliant with Nuclear Regulatory Commission Standards.

12. Contractor must have a Cyclotron (special equipment and building that generates radioactive doses) located within a 2-hour delivery time from the Charlie Norwood VA Medical Center facility. This allows for add-on patient studies during the same day and prior to 14:00 pm. The unit doses must be delivered within specific time periods from the distribution center to the CNVAMC hot lab. Each line item is delivered as unit dose.

13. All packaging of radioactive material MUST BE clearly labeled RADIOACTIVE on the outside of the shipping carton.

14. Contractor shall perform all quality control procedures as required by Federal and State regulatory agencies and Joint Commission.

15. Contractor shall meet all Nuclear Regulatory Commission, Department of Transportation, FDA, OSHA and all other agency rules and regulations (Federal and State).

16. Contractor shall accept returns for credit under the following conditions:

a. Product(s) ordered or shipped in error.
b. Product(s) damaged in shipment
c. Concealed shipping damages
d. Recalled product(s)
e. Outdated products in unopened, original container (specifically authorized for return by manufacturer).

D. CAPABILITY OF PERFORMANCE

Contractors use a Nuclear generator/calculator to calculate a unit dose. The VA will notify the vendor based on the Radionuclide (radioactive material) and dosage for each patient. The Contractor then has a courier to deliver to the CNVAMC hot lab (specially secured room to keep the radioactive dose until time of use). CNVAMC must notify the vendor the day before or the day of, so the doses are prepared for the patient’s procedure/treatment. It is important to have a local vendor that can provide service on time. Radioactive doses are constantly decaying which means the original dose drawn up is measured at half the amount needed within a specific time frame.

QASP Assurance Surveillance Plan:

Accuracy of delivered order: all daily deliveries should match order placed.

Timeliness of deliveries: all daily deliveries should arrive according to paragraph I.1 and 5 above.

Compliance of shipping containers: all containers will be secured and labeled according to NRC and DOT regulations.

Radiation safety review: package surveys and wipes for removable contamination will meet NRC and DOT guidelines.

Communication of industry issues: industry shortages or product recalls will be communicated within 24 hours.

Contractor Performance Assessment Reporting System (CPARS)

FAR 42.1502 directs all Federal agencies to collect past performance information on contracts. The Department of Veterans Affairs (VA) has implemented Contractor Performance Assessment Reporting System (CPARS) to comply with this regulation. One or more past performance evaluations will be conducted in order to record your contract performance as required by FAR 42.15.
The past performance evaluation process is a totally paperless process using CPARS. CPARS isa web-based system that allows for electronic processing of the performance evaluation report. Once the report is processed, it is available in the Past Performance Information Retrieval System (PPIRS) for Government use in evaluating past performance as part of a source selection action.
We request that you furnish the Contracting Officer with the name, position title, phone number, and email address for each person designated to have access to your firm's past performance evaluation(s) for the contract. Each person granted access will have the ability to providecomments in the Contractors portion of the report and state whether or not the Contractor agrees with the evaluation, before returning the report to the Assessing Official. The report information must be protected as source selection sensitive information not releasable to the public.
When your Contractor Representative(s) (Past Performance Points of Contact) are registered inCPARS, they will receive an automatically generated email with detailed login instructions. Further details, systems requirements, and training information for CPARS are available at http://www.cpars.csd.disa.mil/. The CPARS User Manual, registration for Online Training for Contractor Representatives, and a practice application may be found at this site.
The Assessing Official will complete an interim or final past performance evaluation and the report will be accessible at http://www.cpars.csd.disa.mil/. The Contractor Representative has theoption to provide comments on the evaluation, indicate if they concur or do not concur with the evaluation, sign, and then return the evaluation to the Assessing Official. The Contractor Representative has a total of 60 days following the Assessing Official’s evaluation signature date to send comments. If the Contractor Representative sends comments within the first 14 days following the Assessing Official’s signature date and the Assessing Official or ReviewingOfficial closes the evaluation, the evaluation will become available in PPIRS-RC within 1 day. On day 15 following the Assessing Official’s evaluation signature date, the evaluation willbecome available in PPIRS-RC with or without Contractor Representative comments and whether or not it has been closed by the Assessing Official or Reviewing Official. If no Contractor Representative comments have been sent and the evaluation has not been closed, it will be marked as “Pending” in PPIRS-RC. If the Contractor Representative sends comments atany time prior to 61 days following the Assessing Official’s evaluation signature date, those comments will be reflected in PPIRS-RC within 1 day. On day 61 following the AssessingOfficial’s evaluation signature date, the Contractor Representative will be “locked out” of the evaluation and may no longer send comments.

The following guidelines apply concerning Contractor Representative use of the past performance evaluation:

Protect the evaluation as "source selection information." After review, transmit the evaluation by completing and submitting the form through CPARS. If for some reason you are unable to view and/or submit the form through CPARS, contact the Contracting Officer for instructions.

Strictly control access to the evaluation within your organization. Ensure the evaluation is never released to persons or entities outside of your control.

Prohibit the use of or reference to evaluation data for advertising, promotional material, pre award surveys, responsibility determinations, production readiness reviews, or other similar purposes.

E. SCHEDULE FOR DELIVERABLES

The period of performance will be effective for base period September 1, 2020 thru August 31, 2021 with four (4) one-year option periods. The contract is subject to the availability of VA funds. No services shall be performed by the Contractor each calendar year, until the Contracting Officer authorizes such services in writing.
BASE YEAR:September 1, 2020 through August 31, 2021
OPTION YEAR 1:September 1, 2021 through August 31, 2022
OPTION YEAR 2:September 1, 2022 through August 31, 2023
OPTION YEAR 3:September 1, 2023 through August 31, 2024
OPTION YEAR 4:September 1, 2024 through August 31, 2025
Orders can be placed by the CNVAMC ordering personnel via telephone, fax, website portal or e-mail.
The following Federal Holidays are observed:
New Year’s Day
Birthday of Martin Luther King, Jr. (day of observance)
Washington’s Birthday
Memorial Day
Independence Day
Labor Day
Columbus Day
Veterans Day
Thanksgiving Day
Christmas Day
Delivery of supplies by the scheduled date will be complete except as otherwise authorized by the Ordering Personnel.
Radiopharmaceuticals shall be delivered to:
Charlie Norwood VA Medical Center
Downtown Division Room 2D165Nuclear Medicine Department
950 15th Street, Augusta, Georgia 30901
Because of the critical need of these supplies, there must be a 30-minute turnaround delivery time for low energy isotopes, used for emergency patient orders, from the pharmacy distribution site to the hot lab delivery site (CNVAMC, Downtown Division, 2D-165). If for any reason any deliverable cannot be delivered within the scheduled time frame, the Contractor is required to notify the CNVAMC Nuclear Medicine Service by phone or in writing as soon as is feasible.
Point of Contact: The COTR for this contract is Deborah M. Gibbs, Chief Nuclear Medicine/ Imaging Supervisor, telephone number is 706.733-0188, ext. #2886.

F. CHANGES TO STATEMENT OF WORK

Any changes to this SOW shall be authorized and approved only through written correspondence from the CO. A copy of each change will be kept in a project folder along with all other products of the project. Costs incurred by the Contractor through the actions of parties other than the CO shall be borne by the Contractor.

G. RISKS

The requirements are readily available in the commercial marketplace, therefore no design development, or production risks are associated with this procurement. Any technical, schedule or cost risks are considered low as well.

Cost Risk: This will be a firm fixed price contract. Any risk regarding price/cost is incurred by the Contractor.

Schedule: The risk of the Contractor failing to meet the required schedule is minimal. The required services are readily available via the Contractor’s normal course of business. The primary risk would be the Contractor’s failure to provide timely response for the services. However, any risks will be mitigated by frequent communications between the Contractor and the COR or a designated representative.

Technical: The risk of Contractors not performing is minimal. The selected Contractor’s proposal will be evaluated, a statement of work will be included as well as the evaluation criteria. The selected vendor must be deemed technically acceptable for all sub factors.

Acquisition Streamlining: Streamlining efforts have been established for this procurement by utilization of commercial services procurement methods. The Federal Acquisition Regulations (FAR) or supplements thereto will be tailored to the maximum extent practicable to streamline the acquisition process and ensure timely award of the contract.

H. PLAN OF ACTION:

a. Sources: Open market vendors were identified as potential sources of supply. The action plan is to award a firm fixed price contract to a single Contractor. The solicitation will be advertised under NAICS Code 325412, “Pharmaceutical Preparation manufacturing” / Product Service Code Q527 “Medical Services – Nuclear Medicine”.

I. TECHNICAL

The technical factor will be evaluated based upon an assessment of the Offeror’s understanding of the requirement, feasibility or approach, flexibility, adequacy of response and the specific criteria as listed below:

(A) Describe the Contractor’s technical approach to complete the project in accordance with the Statement of Work (SOW):

i. Submit capability statement showing how they intend to meet requirements of contract.

ii. Documentation showing the Contractor has a courier to deliver to the CNVAMC hot lab (specially designed and secured room to keep all radioactive unit doses and sources until time of use).

iii. Documentation showing the Contractor is located within 30 minutes of the medical facility to deliver stat low energy unit doses for emergency patient orders.

iv. Documentation showing the Contractor has a cyclotron (special equipment that generates the radioactive doses) located within 2 hours of the CNVAMC facility. The Contractor can provide emergency and add-on patient studies with each line item delivered as a unit dose.

v. Documentation showing the Contractor is a USP 797 Compliant Pharmacy.

vi. Show the Contractor is able to provide unit doses within 30 minutes or less, same day Iodine capsules, add-on FDG doses, on call services, established weekend operations to provide FDG (PET/CT) doses within 2 hours from distribution site door to CNVAMC hot lab door (2D-165).

vii. Show ability to provide by product material or cyclotron produced materials manufactured, labeled, packaged and distributed in accordance with a license issued pursuant to the regulations in Title 10, Code of Federal Regulations, Part 35 and the equivalent regulations of an Agreement State.

viii. Show ability to have adequate supply of contract products to meet the requirements of System at said distribution point and ability to label all supplies as to amount of radiopharmaceutical/pharmaceutical, preparation time, date, etc. and provide a bar labeled insert to allow scanning data into a Nuclear medicine information system.

ix. Contractor shall provide proof of Dose Management System (ie: Syntrac, Biodose NMIS Ec2 or Nuctrac) for Health Physics, unit doses tracking and Radiation Safety purposes.

x. Contractor shall be made aware of the Quality Assessment factors by which the methods surveillance includes, but not limited to:

1. Direct Observation: 100% surveillance / Inspection of requested/ordered/delivered products.

2. Periodic Inspections: daily, weekly, monthly, quarterly, annually, and unscheduled, as needed.

3. User Survey/Customer Complaints: All complaints will be investigated and validated.

4. Progress/ Status meetings: Monthly or as needed.

J. REVELANT EXPERIENCE / PAST PERFORMANCE

The relevant experience / past performance evaluation will assess the relative risks associated with an offeror’s likelihood of success in performing the solicitation’s requirements as indicated by that offeror’s record of relevant experience /past performance.

a. Offerors that have provided the services for other VA facilities in the past must provide a list with their offer that provides dates of services provided, facility and government point of contact name, telephone and email address and;

b. Offeror’s must provide at least two (2) references of similar facilities where the exact service of performing Radiopharmaceutical services was provided within the last two years (use past performance information survey form) provided within this solicitation and have reference return to contracting activity.

K. ACQUISITON CONSIDFERATIONS

a. The Contracting Officer has determined that the services will be procured via Open Market / Unrestricted under the authority of FAR Part 12.

b. The Contracting Officer has determined that this service will be procured as commercial items under the authority of FAR Parts 12 and 13. Offerors will be evaluated using Lowest Price Technically Acceptable source selection procedures.

c. There is a recurring need for service being acquired. Therefore, the use of options is appropriate for this acquisition. Award will be made for the base year plus four (4) one (1) year options periods.

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM NUMBER
DESCRIPTION OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
1.00
EA
__________________
__________________

Return Kit MED3709 - new item Contract Period: Base POP Begin: 09-01-2020 POP End: 08-31-2021

1.00
EA
__________________
__________________

Return Kit BM01-15 - new item

1.00
EA
__________________
__________________

Tc-99m Bicisate UD - new item

1.00
EA
__________________
__________________

Tc-Exametazime UD - new item

1.00
EA
__________________
__________________

In-111 Capromab Pendetide UD - new item

10.00
EA
__________________
__________________

*Tc-99 Lymphoseek (tilmanocept) - new item The price for Lymphoseek is subject to change upon notice

800.00
EA
__________________
__________________

#0201 - 102192-FDG (item previously on contract)

8.00
EA
__________________
__________________

#0203 - OCTREOSCAN (item previously on contract)

40.00
EA
__________________
__________________

#0204 - I-131 USP NaI Therapy Capsules (1-6 mCi, 40ea. (item previously on contract)

20.00
EA
__________________
__________________

#0205 - Tc-99m Mertiatide UD (MAG-3) (item previously on contract)

1.00
EA
__________________
__________________

#0206 - MED 3709 20 mCi Sheet Source (item previously on contract) RSO request

250.00
EA
__________________
__________________

#0207 - Tc-99m Medronate (item previously on contract)

20.00
EA
__________________
__________________

#0208- Tc-99m DPTA RENAL UD (item previously on contract)

5.00
EA
__________________
__________________

#0209 - IN-111 WHITE BLOOD CELL (item previously on contract)

50.00
EA
__________________
__________________

#0210 - PYP VIAL (item previously on contract)

60.00
EA
__________________
__________________

#0211 - Tc-99m Mebrofenin (choletec) (item previously on contract)

100.00
EA
__________________
__________________

#0212 - I-123 100 uCi Capsule Thyroid Uptake/Scan capsules (item previously on contract)

60.00
EA
__________________
__________________

#0213 - Tc-99m NaTc04 UD (item previously on contract) Muga + GI

60.00
EA
__________________
__________________

#0214 - Tc-99m Sulfur Colloid UD (item previously on contract)

50.00
EA
__________________
__________________

#0215 - Tc-99m DPTA [ AEROSOL ] UD (item previously on contract)

50.00
EA
__________________
__________________

#0217 - Tc-99m MAA UD (item previously on contract)

50.00
EA
__________________
__________________

#0218 - I-131 DX DIAGNOSTIC CAPSULES (<100 uCi), 50 ea. (item previously on contract)

250.00
EA
__________________
__________________

#0219 - I-131 NaI Therapy Capsules, each additional (1-6 mCi),(item previously on contract) We still need to include this because the price of I-131 is for the first 1-6mCi

10.00
EA
__________________
__________________

#0220 - Tc-99m Filtered Sulfur Colloid UD (item previously on contract)

10.00
EA
__________________
__________________

#0222 - Thallous Chloride (Thallium) (item previously on contract)

12.00
EA
__________________
__________________

#0225 - ADAPTABLE/CUSTOMIZABLE SOFTWARE APPLICATION SYNTRAC (item previously on contract)

6.00
EA
__________________
__________________

#0227 - Geiger Muller Survey Calibration (item previously on contract)

5.00
EA
__________________
__________________

#0228 - F-18 Na Flourine PET Bone (item previously on contract)

1.00
EA
__________________
__________________

#0232 - I-123 MIBG (item previously on contract)

POP Begin: 09-01-2020

LOCAL STOCK NUMBER: 4689.00

1.00
EA
__________________
__________________

Misc. Fund - new item

2,000.00
EA
__________________
__________________

#0202 - Generic Sestamibi POP Begin: 10/01/16 POP End: 9/30/17 LOCAL STOCK Number: 102994

5.00
EA
__________________
__________________

#0224 - Tc99m WBC Blood Kit (item previously on contract) POP Begin: 10/1/16 POP End: 9/30/17 LOCAL STOCK

POP Begin: 09-01-2020

LOCAL STOCK NUMBER: 000

1.00
EA
__________________
__________________

Tc99m Ceretec WBC Study

5.00
EA
__________________
__________________

In-111 WBC Kit

5.00
EA
__________________
__________________

In-111 Pentetate Vial

POP Begin: 09-01-2020

5.00
EA
__________________
__________________

TC99m Point Source

50.00
EA
__________________
__________________

I-123 200 uCi Capsule Thyroid

500.00
EA
__________________
__________________

Tc-99m NaTcO4 per mCi (bulk)

50.00
EA
__________________
__________________

Pharmacist Call Out Fee for call outs on weeknights and Saturday Clinic

1.00
EA
__________________
__________________

Syntrac training fee

20.00
EA
__________________
__________________

99mTC Hot Pyrophosphate specifically for Cardiac Amyloidosis

1.00
EA
__________________
__________________

Return Kit MED3709 - new item Contract Period: Option 1 POP Begin: 09-01-2021 POP End: 08-31-2022

1.00
EA
__________________
__________________

Return Kit BM01-15 - new item

1.00
EA
__________________
__________________

Tc-99m Bicisate UD - new item

1.00
EA
__________________
__________________

Tc-Exametazime UD - new item

1.00
EA
__________________
__________________

In-111 Capromab Pendetide UD - new item

10.00
EA
__________________
__________________

*Tc-99 Lymphoseek (tilmanocept) - new item The price for Lymphoseek is subject to change upon notice

800.00
EA
__________________
__________________

#0201 - 102192-FDG (item previously on contract)

8.00
EA
__________________
__________________

#0203 - OCTREOSCAN (item previously on contract)

40.00
EA
__________________
__________________

#0204 - I-131 USP NaI Therapy Capsules (1-6 mCi, 40ea. (item previously on contract)

20.00
EA
__________________
__________________

#0205 - Tc-99m Mertiatide UD (MAG-3) (item previously on contract)

1.00
EA
__________________
__________________

#0206 - MED 3709 20 mCi Sheet Source (item previously on contract) RSO request

250.00
EA
__________________
__________________

#0207 - Tc-99m Medronate (item previously on contract)

20.00
EA
__________________
__________________

#0208- Tc-99m DPTA RENAL UD (item previously on contract)

5.00
EA
__________________
__________________

#0209 - IN-111 WHITE BLOOD CELL (item previously on contract)

50.00
EA
__________________
__________________

#0210 - PYP VIAL (item previously on contract)

60.00
EA
__________________
__________________

#0211 - Tc-99m Mebrofenin (choletec) (item previously on contract)

100.00
EA
__________________
__________________

#0212 - I-123 100 uCi Capsule Thyroid Uptake/Scan capsules (item previously on contract)

60.00
EA
__________________
__________________

#0213 - Tc-99m NaTc04 UD (item previously on contract) Muga + GI

60.00
EA
__________________
__________________

#0214 - Tc-99m Sulfur Colloid UD (item previously on contract)

50.00
EA
__________________
__________________

#0215 - Tc-99m DPTA [ AEROSOL ] UD (item previously on contract)

50.00
EA
__________________
__________________

#0217 - Tc-99m MAA UD (item previously on contract)

50.00
EA
__________________
__________________

#0218 - I-131 DX DIAGNOSTIC CAPSULES (<100 uCi), 50 ea. (item previously on contract)

250.00
EA
__________________
__________________

#0219 - I-131 NaI Therapy Capsules, each additional (1-6 mCi),(item previously on contract) We still need to include this because the price of I-131 is for the first 1-6mCi

10.00
EA
__________________
__________________

#0220 - Tc-99m Filtered Sulfur Colloid UD (item previously on contract)

10.00
EA
__________________
__________________

#0222 - Thallous Chloride (Thallium) (item previously on contract)

12.00
EA
__________________
__________________

#0225 - ADAPTABLE/CUSTOMIZABLE SOFTWARE APPLICATION SYNTRAC (item previously on contract)

6.00
EA
__________________
__________________

#0227 - Geiger Muller Survey Calibration (item previously on contract)

5.00
EA
__________________
__________________

#0228 - F-18 Na Flourine PET Bone (item previously on contract)

1.00
EA
__________________
__________________

#0232 - I-123 MIBG (item previously on contract)

1.00
EA
__________________
__________________

Misc. Fund - new item

2,000.00
EA
__________________
__________________

#0202 - Generic Sestamibi POP Begin: 10/01/16 POP End: 9/30/17 LOCAL STOCK Number: 102994

5.00
EA
__________________
__________________

#0224 - Tc99m WBC Blood Kit (item previously on contract) POP Begin: 10/1/16 POP End: 9/30/17 LOCAL STOCK

1.00
EA
__________________
__________________

Tc99m Ceretec WBC Study

5.00
EA
__________________
__________________

In-111 WBC Kit

5.00
EA
__________________
__________________

In-111 Pentetate Vial

5.00
EA
__________________
__________________

TC99m Point Source

50.00
EA
__________________
__________________

I-123 200 uCi Capsule Thyroid

500.00
EA
__________________
__________________

Tc-99m NaTcO4 per mCi (bulk)

50.00
EA
__________________
__________________

Pharmacist Call Out Fee for call outs on weeknights and Saturday Clinic

1.00
EA
__________________
__________________

Syntrac training fee

20.00
EA
__________________
__________________

99mTC Hot Pyrophosphate specifically for Cardiac Amyloidosis

1.00
EA
__________________
__________________

Return Kit MED3709 - new item Contract Period: Option 2 POP Begin: 09-01-2022 POP End: 08-31-2023

1.00
EA
__________________
__________________

Return Kit BM01-15 - new item

1.00
EA
__________________
__________________

Tc-99m Bicisate UD - new item

1.00
EA
__________________
__________________

Tc-Exametazime UD - new item

1.00
EA
__________________
__________________

In-111 Capromab Pendetide UD - new item

10.00
EA
__________________
__________________

*Tc-99 Lymphoseek (tilmanocept) - new item The price for Lymphoseek is subject to change upon notice

800.00
EA
__________________
__________________

#0201 - 102192-FDG (item previously on contract)

8.00
EA
__________________
__________________

#0203 - OCTREOSCAN (item previously on contract)

40.00
EA
__________________
__________________

#0204 - I-131 USP NaI Therapy Capsules (1-6 mCi, 40ea. (item previously on contract)

20.00
EA
__________________
__________________

#0205 - Tc-99m Mertiatide UD (MAG-3) (item previously on contract)

1.00
EA
__________________
__________________

#0206 - MED 3709 20 mCi Sheet Source (item previously on contract) RSO request

250.00
EA
__________________
__________________

#0207 - Tc-99m Medronate (item previously on contract)

20.00
EA
__________________
__________________

#0208- Tc-99m DPTA RENAL UD (item previously on contract)

5.00
EA
__________________
__________________

#0209 - IN-111 WHITE BLOOD CELL (item previously on contract)

50.00
EA
__________________
__________________

#0210 - PYP VIAL (item previously on contract)

60.00
EA
__________________
__________________

#0211 - Tc-99m Mebrofenin (choletec) (item previously on contract)

100.00
EA
__________________
__________________

#0212 - I-123 100 uCi Capsule Thyroid Uptake/Scan capsules (item previously on contract)

60.00
EA
__________________
__________________

#0213 - Tc-99m NaTc04 UD (item previously on contract) Muga + GI

60.00
EA
__________________
__________________

#0214 - Tc-99m Sulfur Colloid UD (item previously on contract)

50.00
EA
__________________
__________________

#0215 - Tc-99m DPTA [ AEROSOL ] UD (item previously on contract)

50.00
EA
__________________
__________________

#0217 - Tc-99m MAA UD (item previously on contract)

50.00
EA
__________________
__________________

#0218 - I-131 DX DIAGNOSTIC CAPSULES (<100 uCi), 50 ea. (item previously on contract)

250.00
EA
__________________
__________________

#0219 - I-131 NaI Therapy Capsules, each additional (1-6 mCi),(item previously on contract) We still need to include this because the price of I-131 is for the first 1-6mCi

10.00
EA
__________________
__________________

#0220 - Tc-99m Filtered Sulfur Colloid UD (item previously on contract)

10.00
EA
__________________
__________________

#0222 - Thallous Chloride (Thallium) (item previously on contract)

12.00
EA
__________________
__________________

#0225 - ADAPTABLE/CUSTOMIZABLE SOFTWARE APPLICATION SYNTRAC (item previously on contract)

6.00
EA
__________________
__________________

#0227 - Geiger Muller Survey Calibration (item previously on contract)

5.00
EA
__________________
__________________

#0228 - F-18 Na Flourine PET Bone (item previously on contract)

1.00
EA
__________________
__________________

#0232 - I-123 MIBG (item previously on contract)

1.00
EA
__________________
__________________

Misc. Fund - new item

2,000.00
EA
__________________
__________________

#0202 - Generic Sestamibi POP Begin: 10/01/16 POP End: 9/30/17 LOCAL STOCK Number: 102994

5.00
EA
__________________
__________________

#0224 - Tc99m WBC Blood Kit (item previously on contract) POP Begin: 10/1/16 POP End: 9/30/17 LOCAL STOCK

1.00
EA
__________________
__________________

Tc99m Ceretec WBC Study

5.00
EA
__________________
__________________

In-111 WBC Kit

5.00
EA
__________________
__________________

In-111 Pentetate Vial

5.00
EA
__________________
__________________

TC99m Point Source

50.00
EA
__________________
__________________

I-123 200 uCi Capsule Thyroid

500.00
EA
__________________
__________________

Tc-99m NaTcO4 per mCi (bulk)

50.00
EA
__________________
__________________

Pharmacist Call Out Fee for call outs on weeknights and Saturday Clinic

1.00
EA
__________________
__________________

Syntrac training fee

20.00
EA
__________________
__________________

99mTC Hot Pyrophosphate specifically for Cardiac Amyloidosis

1.00
EA
__________________
__________________

Return Kit MED3709 - new item Contract Period: Option 3 POP Begin: 09-01-2023 POP End: 08-31-2024

1.00
EA
__________________
__________________

Return Kit BM01-15 - new item

1.00
EA
__________________
__________________

Tc-99m Bicisate UD - new item

1.00
EA
__________________
__________________

Tc-Exametazime UD - new item

1.00
EA
__________________
__________________

In-111 Capromab Pendetide UD - new item

10.00
EA
__________________
__________________

*Tc-99 Lymphoseek (tilmanocept) - new item The price for Lymphoseek is subject to change upon notice

800.00
EA
__________________
__________________

#0201 - 102192-FDG (item previously on contract)

8.00
EA
__________________
__________________

#0203 - OCTREOSCAN (item previously on contract)

40.00
EA
__________________
__________________

#0204 - I-131 USP NaI Therapy Capsules (1-6 mCi, 40ea. (item previously on contract)

20.00
EA
__________________
__________________

#0205 - Tc-99m Mertiatide UD (MAG-3) (item previously on contract)

1.00
EA
__________________
__________________

#0206 - MED 3709 20 mCi Sheet Source (item previously on contract) RSO request

250.00
EA
__________________
__________________

#0207 - Tc-99m Medronate (item previously on contract)

20.00
EA
__________________
__________________

#0208- Tc-99m DPTA RENAL UD (item previously on contract)

5.00
EA
__________________
__________________

#0209 - IN-111 WHITE BLOOD CELL (item previously on contract)

50.00
EA
__________________
__________________

#0210 - PYP VIAL (item previously on contract)

60.00
EA
__________________
__________________

#0211 - Tc-99m Mebrofenin (choletec) (item previously on contract)

100.00
EA
__________________
__________________

#0212 - I-123 100 uCi Capsule Thyroid Uptake/Scan capsules (item previously on contract)

60.00
EA
__________________
__________________

#0213 - Tc-99m NaTc04 UD (item previously on contract) Muga + GI

60.00
EA
__________________
__________________

#0214 - Tc-99m Sulfur Colloid UD (item previously on contract)

50.00
EA
__________________
__________________

#0215 - Tc-99m DPTA [ AEROSOL ] UD (item previously on contract)

50.00
EA
__________________
__________________

#0217 - Tc-99m MAA UD (item previously on contract)

50.00
EA
__________________
__________________

#0218 - I-131 DX DIAGNOSTIC CAPSULES (<100 uCi), 50 ea. (item previously on contract)

250.00
EA
__________________
__________________

#0219 - I-131 NaI Therapy Capsules, each additional (1-6 mCi),(item previously on contract) We still need to include this because the price of I-131 is for the first 1-6mCi

10.00
EA
__________________
__________________

#0220 - Tc-99m Filtered Sulfur Colloid UD (item previously on contract)

10.00
EA
__________________
__________________

#0222 - Thallous Chloride (Thallium) (item previously on contract)

12.00
EA
__________________
__________________

#0225 - ADAPTABLE/CUSTOMIZABLE SOFTWARE APPLICATION SYNTRAC (item previously on contract)

6.00
EA
__________________
__________________

#0227 - Geiger Muller Survey Calibration (item previously on contract)

5.00
EA
__________________
__________________

#0228 - F-18 Na Flourine PET Bone (item previously on contract)

1.00
EA
__________________
__________________

#0232 - I-123 MIBG (item previously on…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .